Here, a survival curve of glioma patients in relationship to their IGFBP2 gene expression data is shown (Fig. 5A); there are significant differences among high-, low- and intermediate-expressors (Log-rank p-value=6.564E-7, Up-regul. This evidence concerns the gene IGFBP2 and central nervous system cancer.